Prevention of organ failure in hereditary haemochromatosis

Netherlands Journal of Medicine

Volumn 60, Issue 11, 2002, Pages 419-422

  Marx, J J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ARTHRITIS; CARDIOMYOPATHY; CHRONIC HEPATITIS; CONGESTIVE HEART FAILURE; EDITORIAL; FERRITIN BLOOD LEVEL; HEART ARRHYTHMIA; HEMOCHROMATOSIS; HUMAN; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MULTIPLE ORGAN FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; ADULT; DIABETES MELLITUS; LIVER DISEASE; MIDDLE AGED; NOTE;

ADULT; ARTHRITIS; CARDIOMYOPATHIES; DIABETES MELLITUS; HEMOCHROMATOSIS; HUMANS; LIVER DISEASES; MIDDLE AGED;

EID: 0038189839     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (34)

1. McDonnell SM, Preston BL, Jewell SA, et al. A survey of 2,815 patients with haemochromatosis: symptoms and response to treatment. Am J Med 1999;106:619-24.
2. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→ A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
3. Swinkels DW, Aalbers N, Elving LM, Swanink CMA, Meer JWM van der. Primary haemochromatosis: a missed cause of chronic fatigue syndrome? Neth J Med 2002;60:429-33.
4. Ryan E, Byrnes V, Coughlan B, et al. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration? Gut 2002;51:108-12.
5. Adams PC, Agnew S. Alcoholism in hereditary haemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996;23:724-7.
6. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic haemochromatosis. Dig Dis Sci 1982;27:909-16.
7. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986;21:109-13.
8. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;12:882-8.
9. Petry W, Heintges T, Hensel F, et al. Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic. Z Gastroenterol 1997;35:1059-67.
10. Even C, Launoy G, Collet T, et al. Epidemiology of hepatocellular carcinoma in the department of Calvados. Gastroenterol Clin Biol 1997;21:450-8.
11. Yaouanq JM. Diabetes and haemochromatosis: current concepts, management and prevention. Diabete Metab 1995;21:319-29.
12. Conte D, Manachino D, Colli A, et al. Prevalence of genetic haemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med 1998;128:370-3.
13. Frayling T, Ellard S, Grove J, Walker M, Hattersley AT. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet 1998;351:1933-4.
14. Njajou OT, Alizadeh BZ, Vaessen N, et al. The role of haemochromatosis C282Y and H63D gene mutations in type 2 diabetes. Diabetes Care 2002;25:2112-3.
15. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, et al. Prevalence of hereditary haemochromatosis in late-onset type-1 diabetes mellitus: a retrospective study. Lancet 2001;358:1405-9.
16. M'Seffar A, Fornasier VL, Fox IH. Arthropathy as the major clinical indicator of occult iron storage disease. JAMA 1977;238:1825-8.
17. Jensen PS. Haemochromatosis: a disease often silent but not invisible. Am J Roentgenol 1976;126:343-51.
18. Schattenkirchner M, Fischbacher L, Giebner-Fischbacher U, Albert ED. Arthropathy in idiopathic haemochromatosis. Klin Wochenschr 1983;61:1199-207.
19. Sinigaglia L, Fargion S, Fracanzani AL, et al. Bone and joint involvement in genetic haemochromatosis: role of cirrhosis and iron overload. J Rheumatol 1997;24:1809-13.
20. Gottschalk R, Neeck G, Wigand R, Vogtherr B, Kaltwasser JP. Haemochromatosis arthropathy - an early manifestation of genetic haemochromatosis. Z Rheumatol 1997;56:156-62.
21. Olynyk J, Hall P, Ahern M, Kwiatek R, Mackinnon M. Screening for genetic haemochromatosis in a rheumatology clinic. Aust N Z J Med 1994;24:22-5.
22. Finch SC, Finch C. Idiopathic haemochromatosis, an iron storage disease. A. Iron metabolism in haemochromatosis. Medicine (Baltimore) 1955;34:381-430.
23. Milder MS, Cook JD, Stray S, Finch CA. Idiopathic haemochromatosis, an interim report. Medicine (Baltimore) 1980;59:34-49.
24. Edwards CQ, Dadone MM, Skolnick MH, Kushner JP. Hereditary haemochromatosis. Clin Haematol 1982;11:411-35.
25. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary haemochromatosis. N Engl J Med 1985;313:1256-62.
26. Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of haemochromatosis. Adv Exp Med Biol 1994;356:293-302.
27. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Haemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data. Ann Intern Med 1998;129:946-53.
28. Winters GL, Costanzo-Nordin MR. Pathological findings in 2300 consecutive endomyocardial biopsies. Mod Pathol 1991;4:441-8.
29. Rosenqvist M, Hultcrantz R. Prevalence of a haemochromatosis among men with clinically significant bradyarrhythmias. Eur Heart J 1989;10:473-8.
30. Valk B de, Marx JJM. Iron, atherosclerosis and ischaemic heart disease. Arch Intern Med 1999;159:1542-8.
31. Roest M, Schouw YT van der, Marx JJM. Hereditary haemochromatosis: a risk factor for cardiovascular disease. In: Braunwald E (editor). Harrison's Advances in Cardiology. New York: McGraw-Hill, 2002:623-8.
32. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary haemochromatosis: a HuGE review. Am J Epidemiol 2001;154:193-206.
33. Santos M, Sousa M de, Marx JJM. Regulation of intracellular iron levels in iron-acceptor and iron-donor cell. Transfusion Science 2000;23:225-35.
34. Trinder D, Fox C, Vautier G, Olynyk JK. Molecular pathogenesis of iron overload. Gut 2002;51:290-5.